Navin Fluorine International Limited (NAVINFLUOR)
Investor Presentation
AI summary
- Q1 FY27 consolidated revenue Rs 1,045 Cr +44% y-y, operating EBITDA margin 34.2% (+566 bps y-y)
- Operating PBT doubled y-y to Rs 283 Cr; specialty chemicals +48%, CDMO +82%, HPP +33% revenue growth
- Capex underway: HFC capacity expansion (15,000 MTPA) by Q3 FY27, Chemours project by Q2 FY27, cGMP4 phase II by Q4 FY27
- Advanced Materials vertical incubating with Rs 90 Cr capex, targeting Q2 FY28 completion
- Sustainability focus: 30% carbon emission reduction target by 2030, 50% renewable electricity use by 2030
- Strong R&D with Rs 48.7 Cr spend in FY26; digital transformation underway
- Governance: 8 board meetings in FY26, 60% independent directors, active ESG and CSR programs
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 NAVINFLUOR — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add NAVINFLUOR to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Navin Fluorine International Limited
Important.
The summary above is generated automatically from Navin Fluorine International Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.